During the past decade, Urologische Praxis conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urologische Praxis" are "Benign Prostatic Hypertrophy" (1 trials) and "Superficial Bladder Cancer" (1 trials). Many other conditions were trialed in "Urologische Praxis" in a lesser frequency.

Most popular intervention types in "Urologische Praxis" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrorelix 78 + Placebo" (1 trials), "Cetrorelix 78+78" (1 trials), "Mitomycin C" (1 trials), "Placebo" (1 trials) and "abnobaVISCUM 900" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologische Praxis" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Urologische Praxis". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urologische Praxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologische Praxis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".